BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 287 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $9,161,000 | -89.7% | 62,875 | -91.6% | 0.01% | -85.3% |
| Q1 2022 | $89,270,000 | -12.2% | 752,883 | +2.0% | 0.07% | -20.0% |
| Q4 2021 | $101,731,000 | +40.8% | 738,199 | +41.9% | 0.08% | +37.1% |
| Q3 2021 | $72,251,000 | +39598.4% | 520,124 | +27669.6% | 0.06% | – |
| Q2 2021 | $182,000 | +36.8% | 1,873 | -3.7% | 0.00% | – |
| Q1 2021 | $133,000 | -35.4% | 1,945 | -18.9% | 0.00% | – |
| Q4 2020 | $206,000 | +32.1% | 2,398 | 0.0% | 0.00% | – |
| Q3 2020 | $156,000 | -10.9% | 2,398 | 0.0% | 0.00% | – |
| Q2 2020 | $175,000 | +373.0% | 2,398 | +118.0% | 0.00% | – |
| Q1 2020 | $37,000 | -38.3% | 1,100 | 0.0% | 0.00% | – |
| Q4 2019 | $60,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |